Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacy and Therapeutics|December 29, 1998
Determination of compatibility and stability of drugs used in palliative careD Schrijvers, C Tai-Apin, M C De Smet, et al.
Tijdschrift Voor Psychiatrie|December 17, 2014
[Psychometric properties of the Hospital Ethical Climate Survey: a cross-sectional study among Belgian psychiatric nurses]M Claeys, A Faelens, B G C Sabbe, et al.
Journal of Affective Disorders|September 27, 2008
Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: a comparative studyD Schrijvers, F Van Den Eede, Y Maas, et al.
British Journal of Cancer|May 9, 2007
A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumoursM Rasschaert, D Schrijvers, J Van den Brande, et al.
Acta Clinica Belgica|January 1, 1997
Role of hepatic arterial embolisation in the treatment for metastatic insulinoma. Report of two cases and review of the literatureJ Berwaerts, J Verhelst, H Hubens, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 7, 2012
Trait and state aspects of internal and external performance monitoring in schizophreniaS Houthoofd, M Morrens, B Sabbe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Necrotizing skin and soft-tissue infections in the intensive care unitM Peetermans, N de Prost, C Eckmann, et al.
Bone Marrow Transplantation|October 1, 1993
Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMTP Ljungman, R De Bock, C Cordonnier, et al.
Neuropsychobiology|March 10, 2009
Psychomotor changes in major depressive disorder during sertraline treatmentD Schrijvers, Y J Maas, M P B I Pier, et al.
Anticancer Research|July 1, 1985
A phase II study of alternating combination chemotherapy in 55 myeloma patients. A comparison with non-alternating combination chemotherapy and treatment with a single cytostaticE Osby, P Reizenstein, G Mathé, et al.
Pageof 13